All
Results: 63013-63024 of 67588

ResoTher Pharma receives a €2.5 million grant from European Innovation Council (EIC) to support a Phase 2a clinical study of their Lead Candidate RTP-026 for Myocardial Infarction

Alira Health and FORWARD Launch Enhanced Lupus Patient Registry, Accelerating Solutions for Patients









